Related references
Note: Only part of the references are listed.Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
Brett King et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
Brett King et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
K. W. Wyrwich et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Development of the Scalp Hair Assessment PRO™ measure for alopecia areata
Kw Wyrwich et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
Nekma Meah et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
Kathleen W. Wyrwich et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed: a qualitative interview study to understand the psychosocial burden of alopecia areata
Natalie V. J. Aldhouse et al.
JOURNAL OF PATIENT-REPORTED OUTCOMES (2020)
JAK inhibitors for alopecia areata: a systematic review and meta-analysis
K. Phan et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
Ana B. de Oliveira et al.
DERMATOLOGIC THERAPY (2019)
Treatment of alopecia areata: An Australian expert consensus statement
William C. Cranwel et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2019)
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
A. Jabbari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Alopecia areata is associated with impaired health-related quality of life: A survey of affected adults and children and their families
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
An appraisal of new treatment approaches and overview of current therapies
Lauren C. Strazzulla et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
JAK Inhibitors for Treatment of Alopecia Areata
Eddy H. C. Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
JAK inhibitors in dermatology: The promise of a new drug class
William Damsky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Alopecia areata
C. Herbert Pratt et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
Milene Kennedy Crispin et al.
JCI INSIGHT (2016)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
Ali Jabbari et al.
EBIOMEDICINE (2015)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests
Frank Bretz et al.
BIOMETRICAL JOURNAL (2011)
S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents
U. Blume-Peytavi et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
Lynn Petukhova et al.
NATURE (2010)
Lymphocytes, neuropeptides, and genes involved in alopecia areata
Amos Gilhar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Alopecia areata investigational assessment guidelines - Part II
EA Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Share Paper
